Last reviewed · How we verify

NCT06643923

Effects of Lumbopelvic Stabilization-based Physiotherapy and Rehabilitation Training in Duchenne Muscular Dystrophy

Not yet recruiting NA Last updated 16 October 2024
What this trial tests

NA trial testing Exercise in Duchenne Muscular Dystrophy (DMD) in 34 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
1 December 2025
1 December 2026

Quick facts

Lead sponsorLokman Hekim University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment34
Start date1 December 2024
Primary completion1 December 2025
Estimated completion1 December 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Lokman Hekim University

Who can join

Adults 8 to 12, male only, with Duchenne Muscular Dystrophy (DMD) or Lower Urinary Track Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the effectiveness of supervised lumbopelvic stabilization in relation to factors associated with lower urinary tract symptoms in children diagnosed with Duchenne Muscular Dystrophy (DMD) who have lower urinary tract dysfunction. Children aged between 8 and 12 years, at stages 1-4 according to the Vignos scale, and who have a score of 8.5 or higher on the Dysfunctional Voiding Symptom Score (DVSS), will be included in the study. Demographic information will be collected through a general assessment form, while lower urinary tract symptoms will be assessed using the DVSS, a researcher-developed evaluation form, and a three-day bladder diary. Bowel symptoms will be evaluated using the Rome IV criteria and a seven-day bowel diary. Physical performance will be assessed via the Timed Up and Go Test and Gower's Test, muscle strength using the microFET2 hand dynamometer, lumbar lordosis angle with a Bubble inclinometer, participation in daily living activities via the Barthel Index, and perceived well-being of both the child and the parent will be assessed using the Faces Rating Scale. Participants will be randomly assigned to two groups (Treatment and Active Control) using a block randomization method. In the Active Control group, children will receive only urotherapy education. In the Treatment group, children will receive supervised, online, lumbopelvic exercise-based physiotherapy and rehabilitation sessions, in addition to urotherapy, conducted by a physiotherapist. The sessions will last eight weeks, with a total of 24 sessions. At the end of the eight-week period, both groups will be re-evaluated using the same assessment methods. Intra-group and inter-group comparisons will be completed using appropriate analytical methods.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lumbopelvic stabilization-based physiotherapy and rehabilitation and urotherapy for lower urinary tract dysfunction in Duchenne Muscular Dystrophy: a randomized controlled trial.
    Öztürk D, Ayşe Karaduman A, Akbayrak T. · · 2026 · PMID 41663064 · DOI 10.1016/j.jped.2026.101511

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Duchenne Muscular Dystrophy (DMD)

Currently open trials in the same condition.

Other Lokman Hekim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06643923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing